CopyMark Law Group
4.9/5
Drawing for BOSTON BIOMEDICAL PHARMA

USPTO serial 86125352

BOSTON BIOMEDICAL PHARMA

Reviewed by CopyMark Law Group

Reg. 4643788Status 710
Filing date
Status date
Registration date
Nov 25, 2014
Examiner
MCBRIDE, THEODORE M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with BOSTON BIOMEDICAL PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebeccah Gan

Rebeccah Gan WENDEROTH LLP1030 15th Street, NW Suite 400 EastWashington, D.C., DC 20005UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the central nervous system, peripheral nervous system, respiratory system, urogenital system, cardiovascular system, endocrine system, metabolic system, renal system, gastroenterologic system, ophthalmologic system, and dermatologic system; pharmaceutical preparations for the prevention and treatment of hematologic and oncologic disorders and diseases, psychiatric disorders and diseases, allergic disorders and diseases and disorders and diseases of the immune system, connective tissue and joints; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparation for use in chemotherapySECTION 8 - CANCELLED—
042Testing, inspection or research of pharmaceuticalsSECTION 8 - CANCELLED—
044Providing medical informationSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 2, 2021C8..CANCELLED SEC. 8 (6-YR)—
Nov 25, 2019REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 4, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 4, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 3, 2014ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 25, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 11, 2014DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Sep 11, 2014IUCNNOTICE OF ALLOWANCE CANCELLED—
Aug 26, 2014NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 1, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 11, 2014NPUBNOTICE OF PUBLICATION—
May 28, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 27, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 22, 2014DMCCDATA MODIFICATION COMPLETED—
May 14, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 14, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 6, 2014ALIEASSIGNED TO LIE—
Apr 21, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 4, 2014CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 21, 2014DOCKASSIGNED TO EXAMINER—
Dec 6, 2013MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Dec 5, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 25, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance